Screener
AtriCure ATRC Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by AtriCure in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: AtriCure’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 1:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001323885-26-000035
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total Liabilities | 160,210 | 162,244 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ Equity: | ||
| Common stock, $0.001 par value, 90,000 shares authorized and 50,863 and 49,792 issued and outstanding | 51 | 50 |
| Additional paid-in capital | 920,421 | 904,522 |
| Accumulated other comprehensive income | 101 | 566 |
| Accumulated deficit | (404,140) | (413,203) |
| Total Stockholders’ Equity | 516,433 | 491,935 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is AtriCure's common stock, par value (in dollars per share)?
- AtriCure (ATRC) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
- How has AtriCure's common stock, par value (in dollars per share) changed year-over-year?
- AtriCure's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for AtriCure's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), AtriCure's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about AtriCure's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude